Literature DB >> 20306307

Justice and the allocation of healthcare resources: should indirect, non-health effects count?

Kasper Lippert-Rasmussen1, Sigurd Lauridsen.   

Abstract

Alternative allocations of a fixed bundle of healthcare resources often involve significantly different indirect, non-health effects. The question arises whether these effects must figure in accounts of the conditions under which a distribution of healthcare resources is morally justifiable. In this article we defend a Scanlonian, affirmative answer to this question: healthcare resource managers should sometimes select an allocation which has worse direct, health-related effects but better indirect, nonhealth effects; they should do this when the interests served by such a policy are more urgent than the healthcare interests better served by an alternative allocation. We note that there is a prima facie case for the claim that such benefits (and costs) are relevant--i.e. they are real benefits, and in other contexts our decisions can permissibly be guided by them. We then proceed to rebut three lines of argument that might be thought to defeat this prima facie case: they appeal to fairness, the Kantian Formula of Humanity as an End in Itself, and the equal moral worth of persons, respectively.

Entities:  

Mesh:

Year:  2010        PMID: 20306307     DOI: 10.1007/s11019-010-9240-9

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  17 in total

1.  Principles of justice in health care rationing.

Authors:  R Cookson; P Dolan
Journal:  J Med Ethics       Date:  2000-10       Impact factor: 2.903

2.  Health-care needs and distributive justice.

Authors:  Norman Daniels
Journal:  Philos Public Aff       Date:  1981

3.  Justice, health care, and the elderly.

Authors:  Dan W Brock
Journal:  Philos Public Aff       Date:  1989

4.  Managed care at the bedside: how do we look in the moral mirror?

Authors:  Edmund D Pellegrino
Journal:  Kennedy Inst Ethics J       Date:  1997-12

5.  The friction cost method for measuring indirect costs of disease.

Authors:  M A Koopmanschap; F F Rutten; B M van Ineveld; L van Roijen
Journal:  J Health Econ       Date:  1995-06       Impact factor: 3.883

Review 6.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

Review 7.  Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.

Authors:  R J Labelle; J E Hurley
Journal:  J Health Econ       Date:  1992-10       Impact factor: 3.883

8.  The doctor as double agent.

Authors:  M Angell
Journal:  Kennedy Inst Ethics J       Date:  1993-09

9.  "Not clinically indicated": patients' interests or resource allocation?

Authors:  T Hope; D Sprigings; R Crisp
Journal:  BMJ       Date:  1993-02-06

10.  What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D.

Authors:  Stephen J Walters; John E Brazier
Journal:  Health Qual Life Outcomes       Date:  2003-04-11       Impact factor: 3.186

View more
  4 in total

1.  Why Bariatric surgery should be given high priority: an argument from law and morality.

Authors:  Karl Persson
Journal:  Health Care Anal       Date:  2014-12

2.  Are Indirect Benefits Relevant to Health Care Allocation Decisions?

Authors:  Jessica Du Toit; Joseph Millum
Journal:  J Med Philos       Date:  2016-07-26

Review 3.  Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.

Authors:  Lidia Engel; Stirling Bryan; David G T Whitehurst
Journal:  Pharmacoeconomics       Date:  2021-08-23       Impact factor: 4.981

4.  The accountability for reasonableness approach to guide priority setting in health systems within limited resources--findings from action research at district level in Kenya, Tanzania, and Zambia.

Authors:  Jens Byskov; Bruno Marchal; Stephen Maluka; Joseph M Zulu; Salome A Bukachi; Anna-Karin Hurtig; Astrid Blystad; Peter Kamuzora; Charles Michelo; Lillian N Nyandieka; Benedict Ndawi; Paul Bloch; Oystein E Olsen
Journal:  Health Res Policy Syst       Date:  2014-08-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.